๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Postmarketing Re-Evaluation of Irinotecan plus 5-Fluorouracil/Leucovorin for First-Line Treatment of Metastatic Colorectal Cancer

โœ Scribed by Isagani M. Chico; Richard Pazdur

Book ID
119616964
Publisher
CIG Media Group, LP.
Year
2002
Tongue
English
Weight
59 KB
Volume
2
Category
Article
ISSN
1533-0028

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Capecitabine plus oxaliplatin (XELOX) ve
Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer
โœ Michel Ducreux; Jaafar Bennouna; Mohamed Hebbar; Marc Ychou; Gรฉrard Lledo; Thier ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 440 KB

## Abstract A regimen consisting of 5โ€fluorouracil/leucovorin plus oxaliplatin (FOLFOXโ€6) is widely used in France in the firstโ€line treatment of metastatic colorectal cancer (MCRC). The aim of our study was to demonstrate the nonโ€inferiority of capecitabine plus oxaliplatin (XELOX) __versus__ FOLF